Strategic Significance of Low Viral Load of Human Papillomavirus in Uterine Cervical Cytology Specimens
- PMID: 36010208
- PMCID: PMC9406681
- DOI: 10.3390/diagnostics12081855
Strategic Significance of Low Viral Load of Human Papillomavirus in Uterine Cervical Cytology Specimens
Abstract
Infection with high-risk (HR) Human Papillomavirus (HPV) is associated with the development of precancerous lesions or invasive carcinoma of the uterine cervix. Thus, the high viral load (VL) of HR-HPV DNA currently serves as a representative quantitative marker for cervical cancer. However, the clinical significance of low HPV DNA VL remains undetermined. This study aimed to evaluate the clinical association between the low HPV DNA VL and cytology/histologic diagnosis of cervical samples. We searched the electronic medical databases for the resultant analyses of HPV genotyping among patients who underwent treatment for any cervical lesion or who had undergone gynecological examinations with any positive HPV results according to the national cancer screening service between 2015 and 2016. HPV testing with genotyping and semi-quantitative VL measurement was conducted using an AnyplexTM II H28 Detection assay (H28 assay, Seegene, Seoul, Republic of Korea). The H28 assay is a multiplex semi-quantitative real-time PCR test using the tagging of oligonucleotide cleavage and extension (TOCE) technology. The VL was semi-quantified as high (3+; positive signal before 31 PCR cycles), intermediate (2+; positive between 31 and 39 PCR cycles), or low (1+; positive after 40 PCR cycles). Out of 5940 HPV VL analyses, 356 assays (5.99%) were reported as low VL (1+) of HPV DNA. Matched cytology diagnoses were mostly negative findings (n = 347, 97.5%), except for seven cases of atypical squamous cells of undetermined significance (1.9%) and two cases of atypical glandular cells (0.6%). During the follow-up periods, abnormal cytologic diagnoses were identified, including one case of high-grade squamous intraepithelial lesion (HSIL) and two low-grade squamous intraepithelial lesions (LSILs). The matched, confirmative histologic diagnosis of HSIL cytology was compatible with chronic inflammation, wherein the two LSILs had regular check-ups. None revealed clinically concerned outcomes associated with HPV-related squamous lesions. The cytology was most likely negative for malignancy when the VL of HPV DNA was low (1+). Additional strategic monitoring and management may thus be unnecessary.
Keywords: HPV DNA; Human Papillomavirus; cervical cytology; shared decision making; viral load.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:32-36. doi: 10.1016/j.ejogrb.2016.10.005. Epub 2016 Oct 23. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 27816739
-
The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.Obstet Gynecol. 2010 Jul;116(1):76-84. doi: 10.1097/AOG.0b013e3181e3e719. Obstet Gynecol. 2010. PMID: 20567171
-
Prevalence of Human Papillomavirus (HPV) Genotypes in Cervicovaginal Secretions of Human Immunodeficiency Virus (HIV) Positive Indian Women and Correlation With Clinico-Virological Parameters.Front Reprod Health. 2021 Sep 13;3:695254. doi: 10.3389/frph.2021.695254. eCollection 2021. Front Reprod Health. 2021. PMID: 36303978 Free PMC article.
-
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Vaccine. 2012. PMID: 23199969 Review.
-
Trouble-makers in cytologic interpretation of the uterine cervix.J Pathol Transl Med. 2023 May;57(3):139-146. doi: 10.4132/jptm.2023.04.25. Epub 2023 May 15. J Pathol Transl Med. 2023. PMID: 37194148 Free PMC article. Review.
References
-
- WHO Classification of Tumours Editorial Board . WHO Classification of Tumours. 5th ed. Volume 4 International Agency for Research on Cancer (IARC); Lyon, France: 2020. Female Genital Tumours.
Grants and funding
LinkOut - more resources
Full Text Sources